newsfilter
← Latest News
GlobeNewswire·

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

NEWTOWN, Pa., June 22, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ:TRAW, Traws, the Company)), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today